Fig. 4From: Association between P2Y12 inhibitor reloading and in-hospital outcomes for patients with non-ST-segment elevation acute coronary syndrome already on chronic P2Y12 receptor inhibitors therapy in China: findings from the CCC–ACS (improving care for cardiovascular disease in China-acute coronary syndrome) projectSubgroup analysis was performed according to important baseline characteristics in the whole NSTEACS patients, taking into account of MACE. Values are given as number of patients (%). LVEF left ventricular ejection fraction, PCI percutaneous coronary interventionBack to article page